Dean Diagnostics announced that its controlling shareholder, Chen Haibin, and his affiliate Hangzhou Dikong, plan to collectively reduce their stake in the company by no more than 3%. This reduction will be executed through methods such as centralized bidding and block trading. Separately, TCL Zhonghuan released its performance forecast, anticipating a net loss attributable to shareholders of 3 billion to 3.3 billion yuan for the first half of 2026, a reduction from the previous year's loss of 4.24 billion yuan. AI
RANK_REASON The item is a digest of unrelated news items, none of which are significant enough to warrant a higher tier.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
